Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab: Results from eight years of surveillance of clinical practice in the nationwide Danish DANBIO registry-Reference-Cited by-同舟云学术

Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab: Results from eight years of surveillance of clinical practice in the nationwide Danish DANBIO registry

Published:2010-01 Issue:1 Volume:62 Page:22-32
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis Rheum

Author:

Hetland Merete Lund,Christensen Ib Jarle,Tarp Ulrik,Dreyer Lene,Hansen Annette,Hansen Ib TÃ¸nder,Kollerup Gina,Linde Louise,Lindegaard Hanne M.,Poulsen Uta Engling,Schlemmer Annette,Jensen Dorte Vendelbo,Jensen Signe,Hostenkamp Gisela,ÃStergaard Mikkel,

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/art.27227/fullpdf

Reference29 articles.

1. Infliximab and methotrexate in the treatment of rheumatoid arthritis;Lipsky;N Engl J Med,2000

2. Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial;Klareskog;Lancet,2004

3. Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human antiâtumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-controlled, 52-week trial;Keystone;Arthritis Rheum,2004

4. Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis: comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism criteria;Van Gestel;Arthritis Rheum,1996

5. Do changes in prescription practice in patients with rheumatoid arthritis treated with biological agents affect treatment response and adherence to therapy? Results from the nationwide Danish DANBIO Registry;Hetland;Ann Rheum Dis,2008

Cited by 454 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sicherheit und Wirksamkeit der Therapie der rheumatoiden Arthritis im Alter: Was sagen Register- und Routinedaten?;Aktuelle Rheumatologie;2024-08-27

2. Association between dietary retinol intake and rheumatoid arthritis based on NHANES database;BMC Public Health;2024-08-10

3. Drug survival analysis of etanercept compared with monoclonal antibody tumour necrosis factor-α inhibitors in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: a propensity score-matched analysis from the Czech ATTRA registry;Scandinavian Journal of Rheumatology;2024-08-06

4. Optimizing withdrawal strategies for anti-TNF-α therapies in rheumatoid arthritis;Expert Opinion on Biological Therapy;2024-07-25

5. Persistence on subcutaneous tocilizumab as monotherapy or in combination with synthetic disease-modifying anti-rheumatic drugs in rheumatoid arthritis patients in Greece (EMBRACE study): a multicenter, post-marketing, non-interventional, observational trial;Clinical Rheumatology;2024-03-12